CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 30 enrolled
Drug / intervention
Prednisonedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04542278
NCT04542278Phase 4Completed
CompareCT.gov

Randomized Controlled Trial of Preoperative Steroids in Autoimmune Thyroid Disease

University of Wisconsin, Madison·interventional·Posted Sep 9, 2020·Updated Dec 26, 2023

In Brief

A Phase 4 clinical trial evaluating Prednisone for Thyroid Diseases. Completed, enrolled 30 participants across 1 site.

Detailed Summary

This pilot project will randomize a small sample of patients about to undergo surgery for their autoimmune, inflammatory thyroid disease, and determine if a short course of prednisone alters the inflammation of the gland and makes surgery less difficult. It will enroll 30 participants who will each be on study for up to 7 months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsThyroid Diseases
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
202120222023202420252026
First PostedSep 9, 2020
Enrollment StartNov 13, 2020
Primary CompletionOct 4, 2022
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 5.8 years ago

Interventions

Prednisonedrug

used to reduce inflammation